Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.15 USD | -4.60% | +8.36% | -3.26% |
05-08 | BofA Securities Starts Sutro Biopharma With Buy Rating | MT |
04-30 | Sutro Biopharma, Inc. Announces Initiation of Randomized Portion (Part 2) of REFRaME-O1 Trial | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.26% | 339M | |
+3.91% | 109B | |
+10.87% | 105B | |
0.00% | 22.25B | |
-13.14% | 22.09B | |
-8.17% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- STRO Stock
- News Sutro Biopharma, Inc.
- Piper Sandler Adjusts Price Target on Sutro Biopharma to $18 From $16, Maintains Overweight Rating